PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-287

Elanco have had 1000kgs run every year in USA, we found 3 suppliers in USA , Eli Lilly certainly didn't get MPL from India...

Money $$$ can produce wonders Cashtrain , "he who has the Gold calls the shots..."

Global markets have started a downturn , PAA stood up well on Friday ,, News desperately needed to maintain the current sp let alone propel it..

I topped up a few last week , I figure as the clock ticks down as we approach Trial time we should begin to see a sustained climb.

Once the company inform the market of multiple trials starting that always kicks the Company into exciting mode, the Covid Trials will be short , just wish the company started to get the pan hot and disclose Trial Clinics, Patient numbers and duration of trial,,,, must be known as kick off was scheduled in October.. one more week of January left...Tick Tock

Another ASX Biotech listed their trial sites last week and will be recruiting Covid Positive patients this week , obviously you need freshly infected Trial Patients and very regrettably Australia has several hundred thousand

	Cases 2.13M 2,130,000	Deaths 3,043 3,043

	Location	Cases	Deaths
1	New South Wales	940K 940,000	1,052 1,052
2	Victoria	735K 735,000	1,791 1,791
3	Queensland	298K 298,000	85 85
4	South Australia	94,081 94,081	67 67
5	Australian Capital Territory	29,240 29,240	22

Hope Miollard has been more than in touch with Syngene?

SP has been stagnant/eroding for over a year while waiting on the sidelines for MPL ,, googling the one year of deaths would keep me up at night ,,,knowing I had a remarkable Oral Treatment for SARs / every covid variant......but was hamstrung by a single supplier ..FFS